Rafael Holdings Shares Outstanding 2018-2018 | RFL

Rafael Holdings shares outstanding history from 2018 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Rafael Holdings shares outstanding for the quarter ending April 30, 2018 were 0.013B, a INF% increase year-over-year.
  • Rafael Holdings shares outstanding were 0B, a NAN% decline from .
  • Rafael Holdings shares outstanding were 0B, a NAN% decline from .
  • Rafael Holdings shares outstanding were 0B, a NAN% decline from .
Rafael Holdings Annual Shares Outstanding
(Millions of Shares)
Rafael Holdings Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 13
Q2 2018 0
Q4 2017 0
Q3 2017 13
Q2 2017 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.114B $0.000B
Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.706B 11.59
Zoetis (ZTS) United States $43.393B 31.49
Tilray (TLRY) United States $16.426B 0.00
Grifols (GRFS) Spain $14.606B 18.93
Neurocrine Biosciences (NBIX) United States $10.877B 0.00
Nektar Therapeutics (NKTR) United States $10.079B 11.78
Jazz Pharmaceuticals (JAZZ) Ireland $9.929B 14.61
Impax Laboratories (AMRX) United States $7.220B 38.40
Ionis Pharmaceuticals (IONS) United States $6.974B 0.00
Sage Therapeutics (SAGE) United States $6.862B 0.00
Catalent (CTLT) United States $6.228B 26.87
United Therapeutics (UTHR) United States $5.412B 6.95
FibroGen (FGEN) United States $4.976B 0.00
Loxo Oncology (LOXO) United States $4.853B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.944B 15.27
Endo (ENDP) Ireland $3.661B 5.26
Madrigal Pharmaceuticals (MDGL) United States $3.330B 0.00
USANA Health Sciences (USNA) United States $2.954B 26.03
Ironwood Pharmaceuticals (IRWD) United States $2.650B 0.00
Aerie Pharmaceuticals (AERI) United States $2.639B 0.00
Heron Therapeutics (HRTX) United States $2.573B 0.00
Xencor (XNCR) United States $2.534B 0.00
PTC Therapeutics (PTCT) United States $2.328B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.280B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.130B 0.00
TESARO (TSRO) United States $2.076B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.893B 23.15
Portola Pharmaceuticals (PTLA) United States $1.862B 0.00
Zogenix (ZGNX) United States $1.766B 0.00
Corcept Therapeutics (CORT) United States $1.704B 26.21
Arrowhead Pharmaceuticals (ARWR) United States $1.662B 0.00
TherapeuticsMD (TXMD) United States $1.563B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.551B 0.00
Tricida (TCDA) United States $1.548B 0.00
ImmunoGen (IMGN) United States $1.377B 0.00
Endocyte (ECYT) United States $1.240B 0.00
Esperion Therapeutics (ESPR) United States $1.226B 0.00
Karyopharm Therapeutics (KPTI) United States $1.149B 0.00
Radius Health (RDUS) United States $0.856B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.800B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.734B 0.00
Flexion Therapeutics (FLXN) United States $0.714B 0.00
Dova Pharmaceuticals (DOVA) United States $0.695B 0.00
GlycoMimetics (GLYC) United States $0.623B 0.00
ChemoCentryx (CCXI) United States $0.608B 36.38
La Jolla Pharmaceutical (LJPC) United States $0.577B 0.00
OptiNose (OPTN) United States $0.564B 0.00
ArQule (ARQL) United States $0.560B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.553B 0.00
Odonate Therapeutics (ODT) United States $0.548B 0.00
Siga Technologies (SIGA) United States $0.534B 0.00
Collegium Pharmaceutical (COLL) United States $0.521B 0.00
CASI Pharmaceuticals (CASI) United States $0.493B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.488B 0.00
Aclaris Therapeutics (ACRS) United States $0.478B 0.00
Akebia Therapeutics (AKBA) United States $0.475B 0.00
Minerva Neurosciences (NERV) United States $0.473B 0.00
Translate Bio (TBIO) United States $0.468B 0.00
Dermira (DERM) United States $0.459B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.455B 0.00
Xeris Pharmaceuticals (XERS) United States $0.436B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.427B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.424B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 28.73
Aquestive Therapeutics (AQST) United States $0.407B 0.00
Zafgen (ZFGN) United States $0.403B 0.00
Forty Seven (FTSV) United States $0.400B 0.00
Depomed (ASRT) United States $0.396B 0.00
Mast Therapeutics (SVRA) United States $0.394B 0.00
ElectroCore (ECOR) United States $0.391B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.375B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.327B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.322B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
MEI Pharma (MEIP) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.309B 0.00
Opexa Therapeutics (ACER) United States $0.300B 0.00
Aratana Therapeutics (PETX) United States $0.290B 0.00
Galectin Therapeutics (GALT) United States $0.284B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.271B 0.00
Tyme Technologies (TYME) United States $0.268B 0.00
Ardelyx (ARDX) United States $0.261B 0.00
Melinta Therapeutics (MLNT) United States $0.255B 0.00
Ocular Therapeutix (OCUL) United States $0.248B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.241B 0.00
IMV INC (IMV) Canada $0.237B 0.00
Neon Therapeutics (NTGN) United States $0.228B 0.00
Jounce Therapeutics (JNCE) United States $0.225B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.224B 0.00
Lannett Co Inc (LCI) United States $0.214B 1.77
Galmed Pharmaceuticals (GLMD) Israel $0.204B 0.00
Achaogen (AKAO) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 0.00
Aldeyra Therapeutics (ALDX) United States $0.178B 0.00
DURECT (DRRX) United States $0.178B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.177B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Calithera Biosciences (CALA) United States $0.173B 0.00
Immune Design (IMDZ) United States $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.167B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.165B 0.00
Molecular Templates (MTEM) United States $0.157B 0.00
Adherex Technologies (FENC) United States $0.155B 0.00
Recro Pharma (REPH) United States $0.155B 0.00
Cardiome Pharma (CORV) Canada $0.150B 0.00
Neos Therapeutics (NEOS) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.147B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.144B 0.00
ProNAi Therapeutics (SRRA) Canada $0.144B 0.00
Infinity Pharmaceuticals (INFI) United States $0.131B 0.00
ContraFect (CFRX) United States $0.129B 0.00
Forward Pharma (FWP) Denmark $0.124B 0.00
CTI BioPharma (CTIC) United States $0.117B 0.00
BioLineRx (BLRX) Israel $0.115B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.108B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Trillium Therapeutics (TRIL) Canada $0.086B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.080B 0.00
Otonomy (OTIC) United States $0.080B 0.00
Natural Alternatives (NAII) United States $0.075B 8.45
KemPharm (KMPH) United States $0.075B 0.00
Novan (NOVN) United States $0.073B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 53.33
SCYNEXIS (SCYX) United States $0.060B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.049B 25.70
Tokai Pharmaceuticals (NVUS) United States $0.046B 0.00
Genocea Biosciences (GNCA) United States $0.044B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Capnia (SLNO) United States $0.043B 0.00
Onconova Therapeutics (ONTX) United States $0.043B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.039B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Avenue Therapeutics (ATXI) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
PharmAthene (ALT) United States $0.034B 0.00
Lipocine (LPCN) United States $0.032B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
IsoRay (ISR) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
HANCOCK JAFFE (HJLI) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Shineco (TYHT) China $0.023B 1.95
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Aradigm (ARDM) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
Intellipharmaceutics (IPCI) Canada $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Bio-Path Holdings (BPTH) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Pain Therapeutics (PTIE) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
RXi Pharmaceuticals (RXII) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00